Mar 15, 20243 min read
Resoundant Applauds FDA Approval of Resmetirom: A Milestone for MASLD and MASH Patients
Rochester, MN – Resoundant, a Mayo Clinic company and the developer of Magnetic Resonance Elastography (MRE), is thrilled to announce the...